➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Boehringer Ingelheim
Express Scripts
Harvard Business School
Moodys

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Drug Price Trends for TOBRAMYCIN


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for TOBRAMYCIN

Average Pharmacy Cost for TOBRAMYCIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
TOBRAMYCIN-DEXAMETH OPHTH SUSP 61314-0647-25 16.85400 ML 2020-06-17
TOBRAMYCIN 0.3% EYE DROP 17478-0290-10 1.77382 ML 2020-06-17
TOBRAMYCIN 0.3% EYE DROP 24208-0290-05 1.77382 ML 2020-06-17
TOBRAMYCIN 0.3% EYE DROP 62332-0518-05 1.77382 ML 2020-06-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for TOBRAMYCIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
TOBRAMYCIN SO4 1.2GM/VIL INJ X-Gen Pharmaceuticals, Inc. 39822-0412-06 6 383.79 63.96500 EACH 2019-06-01 - 2024-05-31 FSS
TOBRAMYCIN SO4 1.2GM/VIL INJ X-Gen Pharmaceuticals, Inc. 39822-0412-01 1 67.84 67.84000 EACH 2019-06-01 - 2024-05-31 FSS
TOBRAMYCIN 300MG/5ML SOLN,INHL,ORAL,5ML,KIT,5 Genericus, Inc. 70644-0899-99 56x5ML 1315.58 2018-08-15 - 2023-08-14 FSS
TOBRAMYCIN 300MG/5ML SOLN,INHL,ORAL,5ML AvKare, Inc. 65162-0914-46 1X56 1924.13 2018-10-30 - 2022-12-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Johnson and Johnson
McKinsey
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.